Incyte Corp $53.94

down -0.77


28/8/2014 04:00 PM  |  NASDAQ : INCY  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get INCY Trend Analysis - it has outperformed the S&P 500 by 32%

Partner Headlines

  1. UPDATE: Incyte Partners With Genetech to Help With Trials

    Benzinga
  2. Weekly CFO Sells Highlight: Aramark, Incyte Corp Ltd., Facebook Inc.

    GuruFocus
  3. Weekly Insider Sells Highlight: ARMK, INCY, ESC, HUN

    GuruFocus
  4. Surges In Biotech Short Interest (INCY, PCYC, RGEN)

    Benzinga
  5. Mid-Day Losers Mar. 7, 2014: PXLW, ALOG, ALSK, NMRX, NLNK, EMAN

    Benzinga
  6. Morning Movers for Mar. 7, 2014: SKUL, DLIA, BIG, GTAT, CCRN, FL Moving ...

    Benzinga
  7. US Stock Futures Edge Higher; All Eyes On Jobs Report

    Benzinga
  8. UPDATE: Bank of America Reinstates Coverage on Incyte on Two Oncology Platforms

    Benzinga
  9. BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)

    Benzinga
  10. Incyte Q4 swings to a loss

    IBD
  11. Merck soars on cancer deal

    IBD
  12. Merck Q4 Misses, But Cancer Deals Ignite Stock

    IBD
  13. Incyte Names Hervé Hoppenot President and CEO

    Benzinga
  14. Incyte Reports Jakafi Data Continues to Show Improved Overall Survival ...

    Benzinga
  15. UPDATE: Piper Jaffray Initiates Coverage on Incyte as 2014 Biotech Sector ...

    Benzinga
  16. Incyte Completes Offering of $750M of Convertible Senior Notes

    Benzinga
  17. Geron Revealed Positive Imetelstat Results Amidst Data Concerns

    Benzinga
  18. Incyte Announces Positive Phase II Clinical Trial Results of Oral JAK1 ...

    Benzinga
  19. Incyte Reports Positive Results from Phase II Clinical Trial of Oral JAK1 ...

    Benzinga
  20. Weekly CEO Sells Highlight: ExOne Co, Atmel Corporation, Best Buy and Incyte ...

    GuruFocus
  21. Weekly CFO Sells Highlight: INTU, INCY, RLD, MIDD, XONE

    GuruFocus
  22. UPDATE: Jefferies Raises PT on Incyte Following Favorable Phase 2 RECAP ...

    Benzinga
  23. Incyte surges on drug report

    IBD
  24. Benzinga Market Wrap For August 21: FOMC Minutes Send Markets Spinning

    Benzinga
  25. Mid-Afternoon Market Update: Retailers Hurting As Lowe's Rises

    Benzinga
  26. Mid-Day Market Update: Staples Shares Slip On Weak Earnings

    Benzinga
  27. UPDATE: Canaccord Raises PT on Incyte Following Phase 2 RECAP Data Release

    Benzinga
  28. Incyte Stock Soars As Drug Fights Pancreatic Cancer

    IBD
  29. UPDATE: Bank of America Raises PT on Incyte on Compelling New Data

    Benzinga
  30. Mid-Morning Market Update: Markets Mostly Lower; Lowe's Posts Upbeat Profit

    Benzinga
  31. Stocks Hitting 52-Week Highs

    Benzinga
  32. Benzinga's Top Pre-Market Gainers

    Benzinga
  33. UPDATE: UBS Investment Research Raises PT on Incyte Following 2Q13 Results

    Benzinga
  34. Mid-Afternoon Market Update: Bernanke Press Conference Leads to Drop in ...

    Benzinga
  35. Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise

    Benzinga
  36. Gilead Acquiring YM Biosciences For Cancer Drug

    IBD
  37. Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib ...

    Benzinga
  38. Incyte Corp. Reports Operating Results (10-Q)

    GuruFocus
  39. UPDATE: Bank of America Merrill Lynch Reiterates Buy Rating, Lowers PT ...

    Benzinga
  40. Benzinga's Top Initiations

    Benzinga
  41. Incyte Corp. Reports Operating Results (10-Q)

    GuruFocus
  42. Biotechs In Motion As New Drug Pipeline Brims

    IBD
  43. Merck &, Questcor Pharmaceuticals, Other Stocks Hit 52-Week Highs Monday

    FoxBusiness
  44. Lennar Corporation, D.R. Horton Among Stocks Hitting 52-Week Highs Thursday

    FoxBusiness
  45. Social Media Outlook for Tuesday July 3 (INCY, MCS, CLNE, OPEN)

    Benzinga
  46. Health Care Sector Wrap

    FoxBusiness
  47. Piper Jaffray Recommends Incyte (INCY)

    Benzinga
  48. Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive ...

    Benzinga
  49. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga
  50. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga
Trading Center